[Controversies and advances in pathological diagnosis of breast neuroendocrine neoplasms].

Authors

M Zhao, H Bu, B Wei, Y P Liu

Published in

Zhonghua bing li xue za zhi = Chinese journal of pathology. Volume 55. Issue 10. Pages 907-913. Oct 08, 2026.

Abstract

Breast neuroendocrine neoplasms represent a rare pathological entity. Iterative revisions of successive editions of the WHO classification criteria have resulted in poor interobserver consistency in pathological diagnosis. This review systematically sorts out the evolutionary trajectory of the histological subtyping of such neoplasms, comprehensively analyzes diagnostic challenges at the histological, immunohistochemical and molecular levels, and elaborates on the hierarchical diagnostic framework and differential diagnostic criteria proposed by the latest WHO classification. It aims to provide a theoretical reference for the pathological identification of this rare tumor, and facilitate standardized pathological evaluation as well as individualized precision diagnosis and treatment for mammary neuroendocrine neoplasms in clinical practice.

PMID:
42851189
Bibliographic data and abstract were imported from PubMed on 09 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.